Results 11 to 20 of about 2,236,849 (269)

Carbapenem Resistance: A Review [PDF]

open access: yesMedical Sciences, 2017
Carbapenem resistance is a major and an on-going public health problem globally. It occurs mainly among Gram-negative pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii, and may be intrinsic or mediated by ...
Francis S. Codjoe, Eric S. Donkor
doaj   +4 more sources

Insight into the Mechanisms of Carbapenem Resistance in Klebsiella pneumoniae: A Study on IS26 Integrons, Beta-Lactamases, Porin Modifications, and Plasmidome Analysis

open access: yesAntibiotics, 2023
The emergence of carbapenem-resistant Klebsiella pneumoniae poses a significant threat to public health. In this study, we aimed to investigate the distribution and genetic diversity of plasmids carrying beta-lactamase resistance determinants in a ...
Chien-Hao Tseng   +6 more
doaj   +2 more sources

Carbapenem-Resistant Enterobacteriaceae [PDF]

open access: yesClinics in Laboratory Medicine, 2017
Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a major threat. Commonly used antibiotics are generally inactive against CRE. Therefore, timely detection of CRE is of paramount importance. Among CRE, those producing carbapenem-hydrolyzing β-lactamase enzymes (carbapenemase-producing Enterobacteriaceae) are particularly of concern because ...
Alina, Iovleva, Yohei, Doi
  +9 more sources

Molecular Detection of Carbapenem Resistance in Clinical Isolates of Klebsiella pneumoniae in Tertiary Care Hospital [PDF]

open access: yes, 2023
Antibiotic resistance has become a serious global threat, mainly due to misuse, overuse of antibiotics and non-compliance with infection control protocol.
Praful S. Patil   +5 more
core   +1 more source

The Impact of COVID-19 on the Epidemiology of Carbapenem Resistance. [PDF]

open access: yesAntibiotics (Basel)
Background: The global COVID-19 pandemic has significantly disrupted healthcare systems, inadvertently influencing the epidemiology of antimicrobial resistance (AMR).
Sakagianni A   +4 more
europepmc   +2 more sources

Carbapenem resistance in Canada [PDF]

open access: yesCanadian Medical Association Journal, 2009
For more than 2 decades, carbapenems have been considered the pharmacotherapy of last resort for managing multidrug-resistant infections caused by Enterobacteriaceae bacteria (e.g., Escherichia coli and Salmonella ).
Baldwin, Toye   +4 more
openaire   +2 more sources

Carbapenemase-Producing Enterobacterales [PDF]

open access: yes, 2022
Carbapenem-resistant Enterobacterales (CRE) are a common cause of infections in both community and healthcare settings and have become an increasing threat to public health worldwide.

core   +1 more source

Concurrent Resistance to Carbapenem and Colistin Among Enterobacteriaceae Recovered From Human and Animal Sources in Nigeria Is Associated With Multiple Genetic Mechanisms

open access: yesFrontiers in Microbiology, 2021
Resistance to last resort drugs such as carbapenem and colistin is a serious global health threat. This study investigated carbapenem and colistin resistance in 583 non-duplicate Enterobacteriaceae isolates utilizing phenotypic methods and whole genome ...
Emmanuel O. Ngbede   +17 more
doaj   +1 more source

Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae

open access: yesFrontiers in Microbiology, 2022
Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP), a type of Klebsiella pneumoniae (KP) that exhibits hypervirulence and carbapenem resistance phenotypes, can cause severe infections, both hospital- and community-acquired infections.
Yu-Ling Han   +10 more
doaj   +1 more source

Carbapenem Resistance Profile of Acinetobacter baumannii Complex Strains in the Intensive Care Unit of a University Hospital in Northern Cyprus: 3-Year Follow-up [PDF]

open access: yes, 2021
Objective:This study aimed to investigate the distribution of three-year carbapenem resistance of Acinetobacter baumannii complex (ABC) in hospital infections isolated from the intensive care unit in the last three years.Materials and Methods:The ...
Meryem Güvenir   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy